Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 49-60 of 4,306
Behavioral study icon
RecruitingNCT05731414

Outcomes From Remediation and Behavioural Intervention Techniques

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Scarborough Village
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 65 Years
Countries
Canada
Sponsor
University of Toronto
Condition
Schizophrenia
Device study icon
RecruitingNCT07196462

Precision Brain Stimulation to Reduce Cannabis Craving in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Nashville
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 65 Years
Countries
United States
Sponsor
Vanderbilt University Medical Center
Condition
Schizophrenia
Other study type icon
RecruitingNCT06278532

Validation of the Lithuanian Version of the BNSS, CDSS, and the SCoRS

This summary needs review. Please check the official study record and contact the research team for details.

In Kaunas
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, DepressionDiagnostic TestA study that looks at how to detect, measure, or better understand a condition.From 18 Years to 65 Years
Countries
Lithuania
Sponsor
Lithuanian University of Health Sciences
Condition
Schizophrenia, Depression
Behavioral study icon
RecruitingNCT06641297

White Matter Plasticity in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Catonsville
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 15 Years to 45 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
Drug study icon
Not Yet RecruitingNCT07084831

A Study Evaluating the Efficacy of Xanomeline/Trospium (XT) on Cognitive Impairment After 24 and 52 Weeks of Treatment in adults with Schizophrenia

This study is not yet recruiting in Belgium, in Austria, in Czechia, .... It focuses on schizophrenia.

Multiple locations, including Innsbruck
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
Belgium, Austria, Czechia, ...
Sponsor
European Group for Research In Schizophrenia
Condition
Schizophrenia
Behavioral study icon
Not Yet RecruitingNCT07154407

AI-assisted Masticatory Muscle Training in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralOver 20 Years
Countries
Sponsor
Kaohsiung Medical University Chung-Ho Memorial Hospital
Condition
Schizophrenia
Drug study icon
Not Yet RecruitingNCT06924255

Accelerated and Slower Switching to Xanomeline/Trospium Following Atypical Antipsychotic Treatment for schizophrenia

This study is not yet recruiting in the United States. It is testing accelerated and Slower Switching to Xanomeline/Trospium Following Atypical Antipsychotic Treatment for schizophrenia.

Multiple locations, including Bellflower
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Collaborative Neuroscience Research, LLC
Condition
Schizophrenia
Behavioral study icon
Not Yet RecruitingNCT05440955

tDCS for Cognitive Impairment Associated With Recent-onset Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including La Tronche
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 35 Years
Countries
France
Sponsor
University Hospital, Grenoble
Condition
Schizophrenia
Device study icon
RecruitingNCT06107764

Cerebellar Modulation of Cognition in Psychosis

This study is looking at whether a digital support tool can help people with Schizophrenia, schizoaffective disorder, bipolarity I, or Psychosis. Participants take part in a digital support tool and complete follow-up assessments.

Multiple locations, including Belmont
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, BipolarityDeviceFrom 18 Years to 55 Years
Countries
United States
Sponsor
Mclean Hospital
Condition
Schizophrenia, Bipolarity
Behavioral study icon
RecruitingNCT07252206

A Case Series of Culturally-adapted CBTp for Black People in the UK

This summary needs review. Please check the official study record and contact the research team for details.

In Manchester
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralOver 16 Years
Countries
United Kingdom
Sponsor
University of Manchester
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.